Statistics for Arch Biopartners Inc (id:1259 ARCH)

Valuation metrics

Market cap

125.34M

Enterprise value

124.88M

Trailing P/E (ttm)

-36.42

Forward P/E

PEG ratio

Price/Sales (ttm)

90.58

Price/Book (mrq)

Enterprise Value/Revenue

90.26

Enterprise Value/EBITDA

-41.91

Overview

Shares outstanding

64.94M

Float

49.84M

Shares short

3.97K

% Held by insiders

0.20%

% Held by institutions

0.00%

Average volume (10 days)

21.49K

Average volume (90 days)

Price summary

52-Week low

1.10

52-Week high

2.56

52-Week change

41.97%

Beta

1.39

50-Day moving average

1.86

200-Day moving average

1.77

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

September 13th, 2000

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

September 30th, 2023

Most recent quarter (mrq)

March 31th, 2024

Profitability

Profit margin

-185.89%

Operating margin

-138.76%

Operational effectiveness

Return on assets

-81.20%

Return on equity

60.38%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-2,572,050.00

Diluted EPS (ttm)

-0.03

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

43.95K

Total cash per share (mrq)

0.00

Total debt (mrq)

5.32M

Total Debt/Equity (mrq)

-0.83

Current ratio (mrq)

20.30%

Book value per share (mrq)

-0.10

Cash flow

Cash flow statement

-2,716,734.00

Levered free cash flow (LFCF)

-1,504,884.00